A bispecific antibody agonist of the IL-2 heterodimeric receptor preferentially promotes in vivo expansion of CD8 and NK cells

Overview of attention for article published in Scientific Reports, May 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (77th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter: 3 X users

patent: 6 patents

Citations

dimensions_citation: 18 Dimensions

Readers on

mendeley: 80 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 1,589 followers.

A bispecific antibody agonist of the IL-2 heterodimeric receptor preferentially promotes in vivo expansion of CD8 and NK cells https://t.co/oHNOrKL18f https://t.co/TRtekY3WBS

06 Nov 2021

Reply Repost Favourite

A bispecific antibody agonist of the IL-2 heterodimeric receptor preferentially promotes in vivo expansion of CD8 and NK cells by Katherine E Harris https://t.co/fFvE3Z1rFo

20 May 2021

Reply Repost Favourite

Interesting POC by @teneobio. A bispecific Ab to activate IL2Rβγ complex. Greatly increased halflife compared to not-alpha IL-2, tolerability seems surprisingly good. Curious to see the effect of persistent STAT5 signaling on T cell exhaustion $NKTR $NLTX

19 May 2021

Reply Repost Favourite